P10608 (ADRB2_RAT) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 106.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Beta-2 adrenergic receptor Alternative name(s): Beta-2 adrenoreceptor Short name=Beta-2 adrenoceptor | ||||
| Gene names |
| ||||
| Organism | Rattus norvegicus (Rat) | ||||
| Taxonomic identifier | 10116 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus |
Protein attributes
| Sequence length | 418 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Function | Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine. |
| Subunit structure | Binds SLC9A3R1 and GPRASP1. Interacts with ARRB1 and ARRB2. Interacts with SRC, USP20 and USP33. Interacts with VHL; the interaction, which is increased on hydroxylation of ADRB2, ubiquitinates ADRB2 leading to its degradation. Interacts with EGLN3; the interaction hydroxylates ADRB2 facilitating VHL-E3 ligase-mediated ubiquitination By similarity. |
| Subcellular location | Cell membrane; Multi-pass membrane protein By similarity. Note: Colocalizes with VHL on cell membranes By similarity. |
| Post-translational modification | Palmitoylated; may reduce accessibility of Ser-345 and Ser-346 by anchoring Cys-341 to the plasma membrane. Agonist stimulation promotes depalmitoylation and further allows Ser-345 and Ser-346 phosphorylation By similarity. Phosphorylated by PKA and BARK upon agonist stimulation, which mediates homologous desensitization of the receptor. PKA-mediated phosphorylation seems to facilitate phosphorylation by BARK. Phosphorylated upon DNA damage, probably by ATM or ATR By similarity. Phosphorylation of Tyr-141 is induced by insulin and leads to supersensitization of the receptor By similarity. Polyubiquitinated. Agonist-induced ubiquitination leads to sort internalized receptors to the lysosomes for degradation. Deubiquitination by USP20 and USP33, leads to ADRB2 recycling and resensitization after prolonged agonist stimulation. USP20 and USP33 are constitutively associated and are dissociated immediately after agonist stimulation. Ubiquitination by the VHL-E3 ligase complex is oxygen-dependent By similarity. Hydroxylation by EGLN3 occurs only under normoxia and increases the interaction with VHL and the subsequent ubiquitination and degradation of ADRB2 By similarity. |
| Sequence similarities | Belongs to the G-protein coupled receptor 1 family. Adrenergic receptor subfamily. ADRB2 sub-subfamily. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 418 | 418 | Beta-2 adrenergic receptor | PRO_0000069136 | |||||||
Regions | |||||||||||
| Topological domain | 1 – 34 | 34 | Extracellular By similarity | ||||||||
| Transmembrane | 35 – 58 | 24 | Helical; Name=1; By similarity | ||||||||
| Topological domain | 59 – 71 | 13 | Cytoplasmic By similarity | ||||||||
| Transmembrane | 72 – 95 | 24 | Helical; Name=2; By similarity | ||||||||
| Topological domain | 96 – 106 | 11 | Extracellular By similarity | ||||||||
| Transmembrane | 107 – 129 | 23 | Helical; Name=3; By similarity | ||||||||
| Topological domain | 130 – 150 | 21 | Cytoplasmic By similarity | ||||||||
| Transmembrane | 151 – 174 | 24 | Helical; Name=4; By similarity | ||||||||
| Topological domain | 175 – 196 | 22 | Extracellular By similarity | ||||||||
| Transmembrane | 197 – 220 | 24 | Helical; Name=5; By similarity | ||||||||
| Topological domain | 221 – 274 | 54 | Cytoplasmic By similarity | ||||||||
| Transmembrane | 275 – 298 | 24 | Helical; Name=6; By similarity | ||||||||
| Topological domain | 299 – 305 | 7 | Extracellular By similarity | ||||||||
| Transmembrane | 306 – 329 | 24 | Helical; Name=7; By similarity | ||||||||
| Topological domain | 330 – 418 | 89 | Cytoplasmic By similarity | ||||||||
| Region | 193 – 207 | 15 | Agonist and antagonist binding By similarity | ||||||||
| Region | 286 – 293 | 8 | Agonist and antagonist binding By similarity | ||||||||
| Region | 312 – 316 | 5 | Agonist and antagonist binding By similarity | ||||||||
Sites | |||||||||||
| Binding site | 113 | 1 | Agonist or antagonist By similarity | ||||||||
| Binding site | 118 | 1 | Agonist or antagonist By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 141 | 1 | Phosphotyrosine By similarity | ||||||||
| Modified residue | 246 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 261 | 1 | Phosphoserine; by PKA Potential | ||||||||
| Modified residue | 262 | 1 | Phosphoserine; by PKA Potential | ||||||||
| Modified residue | 345 | 1 | Phosphoserine; by PKA By similarity | ||||||||
| Modified residue | 346 | 1 | Phosphoserine; by PKA By similarity | ||||||||
| Modified residue | 355 | 1 | Phosphoserine; by BARK Probable | ||||||||
| Modified residue | 356 | 1 | Phosphoserine; by BARK Probable | ||||||||
| Modified residue | 387 | 1 | 4-hydroxyproline By similarity | ||||||||
| Modified residue | 400 | 1 | 4-hydroxyproline By similarity | ||||||||
| Lipidation | 341 | 1 | S-palmitoyl cysteine By similarity | ||||||||
| Glycosylation | 6 | 1 | N-linked (GlcNAc...) Probable | ||||||||
| Glycosylation | 15 | 1 | N-linked (GlcNAc...) Probable | ||||||||
| Disulfide bond | 106 ↔ 191 | By similarity | |||||||||
| Disulfide bond | 184 ↔ 190 | By similarity | |||||||||
Experimental info | |||||||||||
| Sequence conflict | 262 | 1 | S → F in AAA89068. Ref.2 | ||||||||
| Sequence conflict | 334 | 1 | I → Y in AAA89068. Ref.2 | ||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Primary structure of rat cardiac beta-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequence analysis: further evidence for a multigene family." Gocayne J.D., Robinson D.A., Fitzgerald M.G., Chung F.-Z., Kerlavage A.R., Lentes K.-U., Lai J., Wang C.-D., Fraser C.M., Venter J.C. Proc. Natl. Acad. Sci. U.S.A. 84:8296-8300(1987) [PubMed: 2825184] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Primary structure of the rat beta-2 adrenergic receptor gene." Buckland P.R., Hill R.M., Tidmarsh S.F., McGuffin P. Nucleic Acids Res. 18:682-682(1990) [PubMed: 2155412] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Tissue: Liver. |
| [3] | "Sequence of the 5' regulatory domain of the gene encoding the rat beta 2-adrenergic receptor." Jiang L., Kunos G. Gene 163:331-332(1995) [PubMed: 7590294] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Strain: Sprague-Dawley. |
| [4] | "Structural and functional analysis of the 5'-flanking region of the rat beta 2-adrenergic receptor gene." McGraw D.W., Jacobi S.E., Hiller F.C., Cornett L.E. Biochim. Biophys. Acta 1305:135-138(1996) [PubMed: 8597598] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-23. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | J03024 mRNA. Translation: AAA40675.1. X17607 Genomic DNA. Translation: CAA35609.1. L39264 Genomic DNA. Translation: AAA89068.1. U35448 Genomic DNA. Translation: AAC52449.1. |
| IPI | IPI00192309. |
| PIR | S10855. |
| UniGene | Rn.10206. |
3D structure databases | |
| ProteinModelPortal | P10608. |
| SMR | P10608. Positions 29-348. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | P10608. |
Protein family/group databases | |
| GPCRDB | Search... |
PTM databases | |
| PhosphoSite | P10608. |
Proteomic databases | |
| PRIDE | P10608. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| UCSC | NM_012492. rat. |
Organism-specific databases | |
| RGD | 2060. Adrb2. |
Phylogenomic databases | |
| eggNOG | maNOG17463. |
| HOVERGEN | HBG106962. |
| InParanoid | P10608. |
| OrthoDB | EOG4WQ12W. |
Gene expression databases | |
| ArrayExpress | P10608. |
| Genevestigator | P10608. |
| GermOnline | ENSRNOG00000019217. Rattus norvegicus. |
Family and domain databases | |
| InterPro | IPR000276. 7TM_GPCR_Rhodpsn. IPR000332. Adrgc_rcpt_B2. IPR002233. Adrnrgc_rcpt. IPR017452. GPCR_Rhodpsn_supfam. [Graphical view] |
| Pfam | PF00001. 7tm_1. 1 hit. [Graphical view] |
| PRINTS | PR01103. ADRENERGICR. PR00562. ADRENRGCB2AR. PR00237. GPCRRHODOPSN. |
| PROSITE | PS00237. G_PROTEIN_RECEP_F1_1. 1 hit. PS50262. G_PROTEIN_RECEP_F1_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | ADRB2_RAT | ||||||||
| Accession | Primary (citable) accession number: P10608 Secondary accession number(s): Q6LCR3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| 7-transmembrane G-linked receptors List of 7-transmembrane G-linked receptor entries |
| SIMILARITY comments Index of protein domains and families |

Clusters with